Zero Gravity Solutions, Inc. Announces Appointment of Andrew E. Koopman as President and Chief Executive Officer of Zero Gravity Life Sciences, Inc.

BOCA RATON, Fla.–(BUSINESS WIRE)–Zero
Gravity Solutions, Inc. (“ZGSI” or the “Company”) (Pink Sheets:ZGSI),
an agricultural biotechnology public company commercializing its
technology derived from and designed for Space with significant
applications for agriculture on Earth, announced that Andrew
E. Koopman has been appointed President and Chief Executive Officer
of Zero Gravity Life Sciences, Inc. (ZGLS). ZGLS, a wholly-owned
subsidiary of ZGSI, is focused on expanding the Company’s intellectual
property related to life sciences. The IP was developed from research
conducted on the International Space Station enabled by six NASA
missions.
Mr. Koopman’s initial focus is to coordinate the activities of the
Company’s expanded scientific team, including our research activities
with NASA Ames under the previously announced Space Act Agreement. Mr.
Koopman’s responsibilities also include technical support and research
to diversify the BAM-FX™ product line, grant and IP strategies and
execution.
“Andrew’s background as Director of New Ventures at New York
University’s (NYU) Office of Industrial Liaison provides our Company
with the unique skill sets required to develop intellectual property
into successful commercial business opportunities,” stated Harvey
Kaye, ZGSI’s Chairman of the Board.
“After serving as a Scientific Advisor for Zero Gravity Solutions for
the previous two years and observing the progress made in development
and commercialization of the BAM-FX™ technology, I am excited to join
such an extraordinary team. I look forward to leveraging my
relationships and applying my experience in the translation of
scientific achievements and intellectual property as contribution
towards both the achievement of ZGSI’s critical mission and the
enhancement of shareholder value,” stated Andrew Koopman, ZGLS’s new
President and Chief Executive Officer.
About Zero Gravity Solutions, Inc.
Zero
Gravity Solutions, Inc. (www.zerogsi.com)
is an agricultural biotechnology public company commercializing its
technology derived from and designed for Space with significant
applications on Earth. These technologies are focused on providing
valuable solutions to challenges facing world agriculture. ZGSI’s two
primary categories of technologies aimed at sustainable agriculture are:
1) BAM-FX,
a cost effective, ionic micronutrient delivery system for plants
currently being introduced commercially into world agriculture by Zero
Gravity’s wholly owned subsidiary BAM
Agricultural Solutions and 2) Directed
Selection™, utilized in the development and production, in the
prolonged zero/micro gravity environment of the International Space
Station, of large volumes of non-GMO, novel, patentable stem cells with
unique and beneficial characteristics.
Like
us on Facebook
Follow
us on Twitter
This press release may contain certain forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
Investors are cautioned that such forward-looking statements involve
risks and uncertainties, including without limitation, acceptance of the
Company’s products, increased levels of competition for the Company, new
products and technological changes, the Company’s dependence on
third-party suppliers, and other risks detailed from time to time in the
Company’s periodic reports filed with the Securities and Exchange
Commission. Except as required by applicable law or regulation, Zero
Gravity Solutions undertakes no obligation to update these
forward-looking statements to reflect events or circumstances that occur
after the date on which such statements were made.